Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes

Diabetes Care. 1998 Sep;21(9):1575.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Blood Glucose / metabolism*
  • Dermis / metabolism
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Injections, Subcutaneous
  • Insulin / analogs & derivatives*
  • Insulin / pharmacokinetics
  • Insulin / therapeutic use
  • Insulin Infusion Systems
  • Insulin Lispro
  • Insulin Resistance*
  • Middle Aged
  • Obesity*

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Insulin Lispro